Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer A Meta-analysis
作者： Xavier Paoletti , Koji Oba , Tomasz Burzykowski , Stefan Michiels , Yasuo Ohashi
关键词:
摘要: … Oba K, Morita S, Tsuburaya A, Kodera Y, Kobayashi M, Sakamoto J. Efficacy of adjuvant chemotherapy using oral fluorinated pyrimidines for curatively resected gastric cancer: A meta-…
uhasselt.be
elsevier.com
sci-hub.se 参考文章(51)
R. Jakesz, C. Dittrich, J. Funovics, F. Hofbauer, H. Rainer, G. Reiner, M. Schemper, R. Schiessel, M. Starlinger, The Effect of Adjuvant Chemotherapy in Gastric Carcinoma Is Dependent on Tumor Histology: 5- Year Results of a Prospective Randomized Trial Combined Modality Therapy of Gastrointestinal Tract Cancer. ,vol. 110, pp. 44- 51 ,(1988) , 10.1007/978-3-642-83293-2_6
WilliamH. Allum, MichaelT. Hallissey, KrystynaA. Kelly, British Stomach Cancer Group, ADJUVANT CHEMOTHERAPY IN OPERABLE GASTRIC CANCER: 5 Year Follow-up of First British Stomach Cancer Group Trial The Lancet. ,vol. 333, pp. 571- 574 ,(1989) , 10.1016/S0140-6736(89)91607-3
Michel Huguier, Jean-Pierre Destroyes, Christian Baschet, François Le Henand, Philippe-Francois Bernard, Gastric carcinoma treated by chemotherapy after resection: a controlled study. American Journal of Surgery. ,vol. 139, pp. 197- 199 ,(1980) , 10.1016/0002-9610(80)90253-6
P. Kleihues, B. W. Stewart, World Cancer Report ,(2003)
M Lise, D Nitti, A Marchet, T Sahmoud, M Buyse, N Duez, M Fiorentino, J G Dos Santos, R Labianca, P Rougier, Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer. Journal of Clinical Oncology. ,vol. 13, pp. 2757- 2763 ,(1995) , 10.1200/JCO.1995.13.11.2757
V. Boige, J. Pignon, B. Saint-Aubert, P. Lasser, T. Conroy, O. Bouché, P. Segol, L. Bedenne, P. Rougier, M. Ychou, Final results of a randomized trial comparing preoperative 5-fluorouracil (F)/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial Journal of Clinical Oncology. ,vol. 25, pp. 4510- 4510 ,(2007) , 10.1200/JCO.2007.25.18_SUPPL.4510
R C Coombes, P S Schein, C E Chilvers, J Wils, G Beretta, J M Bliss, A Rutten, D Amadori, H Cortes-Funes, A Villar-Grimalt, A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group. Journal of Clinical Oncology. ,vol. 8, pp. 1362- 1369 ,(1990) , 10.1200/JCO.1990.8.8.1362
PATRICIA M. GRAMBSCH, TERRY M. THERNEAU, Proportional hazards tests and diagnostics based on weighted residuals Biometrika. ,vol. 81, pp. 515- 526 ,(1994) , 10.1093/BIOMET/81.3.515
Michael Schemper, Terry L. Smith, A note on quantifying follow-up in studies of failure time Controlled Clinical Trials. ,vol. 17, pp. 343- 346 ,(1996) , 10.1016/0197-2456(96)00075-X
Juan J. Grau, Jordi Estapé, Felipe Alcobendas, Cristobal Pera, Montserrat Daniels, José Terés, Positive results of adjuvant mitomycin-C in resected gastric cancer: A randomised trial on 134 patients European Journal of Cancer. ,vol. 29, pp. 340- 342 ,(1993) , 10.1016/0959-8049(93)90381-O